USANA Health Sciences (NYSE: USNA) reported Q1 EPS of $0.73, $0.07 worse than the analyst estimate of $0.80. Revenue for the quarter came in at $250 million versus the consensus estimate of $243.15 million.

GUIDANCE:

USANA Health Sciences sees FY2025 EPS of $2.35-$3.00, versus the consensus of $2.59. USANA Health Sciences sees FY2025 revenue of $920-1000 million, versus the consensus of $941.6 million.

For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.